These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 14681060)

  • 1. E-cadherin binding modulates EGF receptor activation.
    Fedor-Chaiken M; Hein PW; Stewart JC; Brackenbury R; Kinch MS
    Cell Commun Adhes; 2003; 10(2):105-18. PubMed ID: 14681060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced activation of epidermal growth factor receptor caused by tumor-derived E-cadherin mutations.
    Bremm A; Walch A; Fuchs M; Mages J; Duyster J; Keller G; Hermannstädter C; Becker KF; Rauser S; Langer R; von Weyhern CH; Höfler H; Luber B
    Cancer Res; 2008 Feb; 68(3):707-14. PubMed ID: 18245470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Motility enhancement by tumor-derived mutant E-cadherin is sensitive to treatment with epidermal growth factor receptor and phosphatidylinositol 3-kinase inhibitors.
    Fuchs M; Hutzler P; Brunner I; Schlegel J; Mages J; Reuning U; Hapke S; Duyster J; Hirohashi S; Genda T; Sakamoto M; Uberall F; Höfler H; Becker KF; Luber B
    Exp Cell Res; 2002 Jun; 276(2):129-41. PubMed ID: 12027444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and tyrosine phosphorylation of E-cadherin, beta- and gamma-catenin, and epidermal growth factor receptor in cervical cancer cells.
    Moon HS; Choi EA; Park HY; Choi JY; Chung HW; Kim JI; Park WI
    Gynecol Oncol; 2001 Jun; 81(3):355-9. PubMed ID: 11371122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cadherin switching: essential for behavioral but not morphological changes during an epithelium-to-mesenchyme transition.
    Maeda M; Johnson KR; Wheelock MJ
    J Cell Sci; 2005 Mar; 118(Pt 5):873-87. PubMed ID: 15713751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of melanocytic malignancy by keratinocytes is an E-cadherin-mediated process overriding beta-catenin signaling.
    Li G; Fukunaga M; Herlyn M
    Exp Cell Res; 2004 Jul; 297(1):142-51. PubMed ID: 15194432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Density-dependent inhibition of growth involves prevention of EGF receptor activation by E-cadherin-mediated cell-cell adhesion.
    Takahashi K; Suzuki K
    Exp Cell Res; 1996 Jul; 226(1):214-22. PubMed ID: 8660958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EGFR regulates RhoA-GTP dependent cell motility in E-cadherin mutant cells.
    Mateus AR; Seruca R; Machado JC; Keller G; Oliveira MJ; Suriano G; Luber B
    Hum Mol Genet; 2007 Jul; 16(13):1639-47. PubMed ID: 17510211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamics of cell adhesion and motility in living cells is altered by a single amino acid change in E-cadherin fused to enhanced green fluorescent protein.
    Fuchs M; Hutzler P; Handschuh G; Hermannstädter C; Brunner I; Höfler H; Luber B
    Cell Motil Cytoskeleton; 2004 Sep; 59(1):50-61. PubMed ID: 15259055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal growth factor receptor (EGFR) signaling in cancer.
    Normanno N; De Luca A; Bianco C; Strizzi L; Mancino M; Maiello MR; Carotenuto A; De Feo G; Caponigro F; Salomon DS
    Gene; 2006 Jan; 366(1):2-16. PubMed ID: 16377102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cadherin enhances cell-matrix adhesiveness by regulating beta1 integrin trafficking in cutaneous squamous carcinoma cells.
    Mukoyama Y; Utani A; Matsui S; Zhou S; Miyachi Y; Matsuyoshi N
    Genes Cells; 2007 Jun; 12(6):787-96. PubMed ID: 17573778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-regulation of E-cadherin by an anti-epidermal growth factor receptor monoclonal antibody in lung cancer cell lines.
    Al Moustafa AE; Yansouni C; Alaoui-Jamali MA; O'Connor-McCourt M
    Clin Cancer Res; 1999 Mar; 5(3):681-6. PubMed ID: 10100722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EGFR-dependent migration of glial cells is mediated by reorganisation of N-cadherin.
    Rappl A; Piontek G; Schlegel J
    J Cell Sci; 2008 Dec; 121(Pt 24):4089-97. PubMed ID: 19033391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced E-cadherin expression in epidermal growth factor receptor expressing cells.
    Sorscher SM; Green MR; Feramisco JR
    Biochem Biophys Res Commun; 1995 Jan; 206(2):518-24. PubMed ID: 7826368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
    Huang Y; Li X; Jiang J; Frank SJ
    Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal growth factor receptor activation in prostate cancer by three novel missense mutations.
    Cai CQ; Peng Y; Buckley MT; Wei J; Chen F; Liebes L; Gerald WL; Pincus MR; Osman I; Lee P
    Oncogene; 2008 May; 27(22):3201-10. PubMed ID: 18193092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Y-box-binding protein 1 confers EGF independence to human mammary epithelial cells.
    Berquin IM; Pang B; Dziubinski ML; Scott LM; Chen YQ; Nolan GP; Ethier SP
    Oncogene; 2005 Apr; 24(19):3177-86. PubMed ID: 15735691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DU145 human prostate carcinoma invasiveness is modulated by urokinase receptor (uPAR) downstream of epidermal growth factor receptor (EGFR) signaling.
    Mamoune A; Kassis J; Kharait S; Kloeker S; Manos E; Jones DA; Wells A
    Exp Cell Res; 2004 Sep; 299(1):91-100. PubMed ID: 15302576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of the cytoplasmic domain of E-cadherin on endogenous N-cadherin expression in malignant melanoma.
    Kuphal S; Bosserhoff AK
    Oncogene; 2006 Jan; 25(2):248-59. PubMed ID: 16132038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of RhoA-GTP induces activation of the Epidermal Growth Factor Receptor, dephosphorylation of focal adhesion kinase and increased motility in breast cancer cells.
    Cáceres M; Guerrero J; Martínez J
    Exp Cell Res; 2005 Sep; 309(1):229-38. PubMed ID: 15963982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.